Adaptive Clinical Systems: Liberating Data from Silos to Accelerate Clinical Trials

With a flexible iPaaS architecture, a client’s clinical know-how is modified in the context of each individual drug development cycle. Once the company, as part of its services, establishes the workflow and data transfer rules through the eClinical Bus, Adaptive Clinical’s knowledgeable staff performs all necessary compliance related testing and certification. After the changes have been applied, the entire Adaptive eClinical Bus framework is recertified on an ongoing basis, which is an added advantage for CIOs.

As there can be uncertainties during the drug development lifecycle, the pay-as-you-go business model allows for a predictable cost structure for CFOs that want to utilize the Adaptive eClinical Bus. Clients need not be concerned about a significant capital investment upfront.

“Our partners have reinforced our market value in that they rely on us to deliver a cohesive solution to their important customers,” says Adibi, who has over 25 years of experience in healthcare and life sciences informatics and business process outsourcing. The company’s messaging has resonated well with CROs and specialty companies like Core Laboratories where improving on their data quality and reliability through interoperability have been top of mind for the data managers. In the ever-evolving pharma industry, Adaptive Clinical has benefitted from staying nimble. As pioneers of cloud-based electronic data capture, the company leveraged that to offer controlled medical vocabularies in an open-source model, followed by providing true interoperability with EMRs and EHRs.

“In the coming months, we are finalizing our 2019 go-to-market strategy leveraging new channels and addressing the pain points and needs of our constituency,” says Adibi. As the established vendor of record for attaining true interoperability, the company will expand its partners’ portfolio through establishing strategic relationships with new and emerging EHRs/ EMRs, eClinical vendors, as well as manufacturers of medical devices and medical monitoring wearables. Adaptive Clinical will continue to participate and work closely with industry-wide consortia and regulatory task forces to promote and establish interoperability as a requirement for drug discovery.